-
Mashup Score: 3Rod Nordland: One of the Lucky Few | Neurological Surgery - 12 day(s) ago
When I first spoke to Rod Nordland about his diagnosis, I gave him the news as kindly and directly as I could. I do that with all my patients — I believe doctors should be honest as well as gentle when talking about a serious diagnosis. And Rod’s brain tumor was a glioblastoma multiforme (GBM), which is as serious as it gets, with a median survival time of about 15 months.
Source: neurosurgery.weillcornell.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Rod Nordland: One of the Lucky Few | Neurological Surgery - 2 month(s) ago
When I first spoke to Rod Nordland about his diagnosis, I gave him the news as kindly and directly as I could. I do that with all my patients — I believe doctors should be honest as well as gentle when talking about a serious diagnosis. And Rod’s brain tumor was a glioblastoma multiforme (GBM), which is as serious as it gets, with a median survival time of about 15 months.
Source: neurosurgery.weillcornell.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Rod Nordland: One of the Lucky Few | Neurological Surgery - 3 month(s) ago
When I first spoke to Rod Nordland about his diagnosis, I gave him the news as kindly and directly as I could. I do that with all my patients — I believe doctors should be honest as well as gentle when talking about a serious diagnosis. And Rod’s brain tumor was a glioblastoma multiforme (GBM), which is as serious as it gets, with a median survival time of about 15 months.
Source: neurosurgery.weillcornell.orgCategories: General Medicine News, NeurologyTweet
Rod Norland had something on his side that not every #glioblastoma patient does: luck. Read my blog post about this amazing patient. https://t.co/7RxF61dMRh https://t.co/uNjUCBCdaD